You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

News

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

As previously announced, Getinge made a public tender offer on December 8 for all of the shares outstanding in the medical equipment company Huntleigh Technology Plc (“Huntleigh”), which is listed on the London Stock Exchange.

Getinge today acquired an additional 2,842,570 Huntleigh shares, corresponding to approximately 3.33% of the total number of Huntleigh shares. The consideration for these shares amounted to GBP 13.6 million, corresponding to GBP 4.80 per share. The number of acquired shares now totals 21.52% of the total number of Huntleigh shares. In addition to the acquired shares, the principal shareholder, the Schild family, and certain other shareholders who jointly represent 46.2%, are still subject to an irrevocable undertaking to accept the offer made by Getinge AB.



For further information:
Johan Malmquist, Managing Director and Chief Executive Officer
Ulf Grunander, Chief Financial Officer


Getinge AB
Ekebergsvägen 26, PO Box 69
SE-310 44 Getinge, Sweden
Phone: +46 [0] 35 15 55 78
Fax: +46 [0] 35 549 52
info@getinge.com
www.getinge.com

MEMBER OF THE GETINGE GROUP

Files

Share: